Tumor metabolism and prognostic role of EZH2 in non-small cell lung cancer

被引：6

作者：

Lopci, Egesta ^{[1
]}

Rossi, Sabrina ^{[2
]}

机构：

[1] Humanitas Clin & Res Hosp, Nul Med, Milan, Italy

[2] Humanitas Clin & Res Hosp, Med Oncol, Milan, Italy

来源：

TRANSLATIONAL CANCER RESEARCH | 2017年 / 6卷

关键词：

ZESTE HOMOLOG 2; MUTATION STATUS; F-18-FDG UPTAKE; ADENOCARCINOMA; EXPRESSION; EGFR; CARCINOMA; PET/CT; PHOSPHORYLATION; PROGRESSION;

D O I：

10.21037/tcr.2017.06.42

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S982 / S988

页数：7

共 39 条

[1] The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers [J].

Apostolova, Ivayla ;

Ego, Kilian ;

Steffen, Ingo G. ;

Buchert, Ralph ;

Wertzel, Heinz ;

Achenbach, H. Jost ;

Riedel, Sandra ;

Schreiber, Jens ;

Schultz, Meinald ;

Furth, Christian ;

Derlin, Thorsten ;

Amthauer, Holger ;

Hofheinz, Frank ;

Kalinski, Thomas .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (13) :2360-2373

[2] EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma [J].

Behrens, Carmen ;

Solis, Luisa M. ;

Lin, Heather ;

Yuan, Ping ;

Tang, Ximing ;

Kadara, Humam ;

Riquelme, Erick ;

Galindo, Hector ;

Moran, Cesar A. ;

Kalhor, Neda ;

Swisher, Stephen G. ;

Simon, George R. ;

Stewart, David J. ;

Lee, J. Jack ;

Wistuba, Ignacio I. .

CLINICAL CANCER RESEARCH, 2013, 19 (23) :6556-6565

[3]

Caicedo C, 2014, EUR J NUCL MED MOL I, V41, P2058, DOI 10.1007/s00259-014-2833-4

[4] EZH2 Promotes Malignant Behaviors via Cell Cycle Dysregulation and Its mRNA Level Associates with Prognosis of Patient with Non-Small Cell Lung Cancer [J].

Cao, Wei ;

Ribeiro, Rachel de Oliveira ;

Liu, Diane ;

Saintigny, Pierre ;

Xia, Ronghui ;

Xue, Yuwen ;

Lin, Ruxian ;

Mao, Li ;

Ren, Hening .

PLOS ONE, 2012, 7 (12)

[5] High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer [J].

Chen, Xiaohui ;

Song, Ning ;

Matsumoto, Keitaro ;

Nanashima, Atsushi ;

Nagayasu, Takeshi ;

Hayashi, Tomayoshi ;

Ying, Mingang ;

Endo, Daisuke ;

Wu, Zhiren ;

Koji, Takehiko .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (05) :1467-1480

[6] Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer [J].

Cho, Arthur ;

Hur, Jin ;

Moon, Yong Wha ;

Hong, Sae Rom ;

Suh, Young Joo ;

Kim, Yun Jung ;

Im, Dong Jin ;

Hong, Yoo Jin ;

Lee, Hye-Jeong ;

Kim, Young Jin ;

Shim, Hyo Sup ;

Lee, Jae Seok ;

Kim, Joo-Hang ;

Choi, Byoung Wook .

BMC CANCER, 2016, 16

[7] Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT [J].

Choi, Hongyoon ;

Paeng, Jin Chul ;

Kim, Dong-Wan ;

Lee, June Koo ;

Park, Chang Min ;

Kang, Keon Wook ;

Chung, June-Key ;

Lee, Dong Soo .

LUNG CANCER, 2013, 79 (03) :242-247

[8] Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer [J].

De Rosa, Viviana ;

Iommelli, Francesca ;

Monti, Marcello ;

Fonti, Rosa ;

Votta, Giuseppina ;

Stoppelli, Maria Patrizia ;

Del Vecchio, Silvana .

CLINICAL CANCER RESEARCH, 2015, 21 (22) :5110-5120

[9] EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer [J].

Geng, Jian ;

Li, Xiao ;

Zhou, Zhanmei ;

Wu, Chin-Lee ;

Dai, Meng ;

Bai, Xiaoyan .

CANCER LETTERS, 2015, 359 (02) :275-287

[10] Critical roles of non-histone protein lysine methylation in human tumorigenesis [J].

Hamamoto, Ryuji ;

Saloura, Vassiliki ;

Nakamura, Yusuke .

NATURE REVIEWS CANCER, 2015, 15 (02) :110-124

← 1 2 3 4 →